Clinical Trials

Acupuncture for Chronic Pain: What the Guidelines Actually Say

A majority of clinical practice guideline recommendations support it. Almost none of them support it strongly. Both facts come from the same review, and the gap between them is the whole story.

Revuelt Health · August 9, 2026 · 9 min read

MDMA-Assisted Therapy After the Rejection: Where the Work Stands

A Phase 3 programme produced some of the largest effect sizes in modern psychiatry. The regulator was not persuaded — and what it objected to was not, in the main, the effect size.

Revuelt Health · August 9, 2026 · 10 min read

The New Wave of Psilocybin Trials for Treatment-Resistant Depression

Phase II results were striking enough to sustain a decade of interest. The larger trials now underway will decide whether the effect holds outside a small, carefully selected room.

Revuelt Health · July 21, 2026 · 9 min read

TMS Therapy, and the Five-Day Protocol That Changed the Conversation

Magnetic stimulation of the prefrontal cortex has been FDA-cleared for depression since 2008. Stanford's accelerated version compressed six weeks into five days.

Revuelt Health · July 18, 2026 · 9 min read

Updated August 5, 2026

Photobiomodulation: What Red and Near-Infrared Light Can and Cannot Do

Light therapy has moved from fringe device to serious research question. The evidence is strongest exactly where the marketing is quietest.

Revuelt Health · June 2, 2026 · 6 min read

Updated July 31, 2026